[International frontier advances and practice in the diagnosis and management of pseudomyxoma peritonei].
The academic research course of pseudomyxoma peritonei (PMP) has been tortuous and long. It is not until the past 40 years that a cognitive system consistent with the core theories of oncology has gradually been formed, and the level of clinical diagnosis and treatment has also made considerable progress. A comprehensive treatment technology system centered on cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been established. This article sorts out and summarizes the cutting-edge research progress in the field of PMP at the 15th International Peritoneal Cancer Congress, combines clinical practice to explore its enlightenment for clinical work, scientific research exploration, and the construction of peritoneal oncology discipline in China, aiming to provide reference for the standardized diagnosis and treatment of PMP and related research in China.